Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
A role for human brain pericytes in neuroinflammation.
Genetic proof for the transient nature of the Th17 phenotype.
A Case Report of Obsessive-Compulsive Disorder Following Acute Disseminated Encephalomyelitis.
Patient taking Novartis MS pill developed rare disease
Introduction: occupational therapy practice and research with persons with multiple sclerosis.
Cross-reactivity between human cytomegalovirus peptide 981-1003 and myelin oligodendroglia glycoprotein peptide 35-55 in experimental autoimmune encephalomyelitis in Lewis rats.
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis.
In vivo immunomodulatory effect of the lectin from edible mushroom Agaricus bisporus.
Myelination Is Associated with Processing Speed in Early Childhood: Preliminary Insights.
Aquaporin-4 mediates communication between astrocyte and microglia: Implications of neuroinflammation in experimental Parkinson's disease.
Restless legs syndrome in Iranian patients with multiple sclerosis.
Recent advances in treating multiple sclerosis: efficacy, risks and place in therapy.
Steps Per Day Among Persons With Multiple Sclerosis: Variation by Demographic, Clinical, and Device Characteristics.
The protective effect of berberine against neuronal damage by inhibiting matrix metalloproteinase-9 and laminin degradation in experimental autoimmune encephalomyelitis.
Natalizumab therapy for multiple sclerosis.
Quantitative Susceptibility Mapping of Multiple Sclerosis Lesions at Various Ages.
Obesity and HLA in multiple sclerosis: Weighty matters.
Empyema presenting as lower extremity weakness.
Liposomal corticosteroids for the treatment of inflammatory disorders and cancer.
Trigeminal neuralgia: a condition to be better understood.
Eight-and-a-half syndrome as presenting sign of childhood multiple sclerosis.
Difficulties with emotion regulation in multiple sclerosis: Links to executive function, mood, and quality of life.
Statistical colocalization of genetic risk variants for related autoimmune diseases in the context of common controls.
Mesenchymal stem cells: A new diagnostic tool?
Pages
« first
‹ previous
…
434
435
436
437
438
439
440
441
442
…
next ›
last »